Sema4: Rachel Sherman

Genetic testing and informatics firm Sema4 has appointed Rachel Sherman to its board of directors.

Sherman is a former principal deputy commissioner of food and drugs at the US Food and Drug Administration. Her career at FDA spanned almost three decades and she oversaw HIV drug development, directed the Critical Path initiative, launched expedited review, and guided the establishment of the oncology center of excellence program.

She is currently a drug development, regulatory, and policy consultant at a firm she founded last year after retiring from FDA, and a lecturer at Harvard Medical School's Department of Population Medicine. She also serves on the board of Aptinyx, a pharmaceutical firm.

Sherman holds an MD from Mount Sinai School of Medicine and a master's degree in public health from Johns Hopkins University.